Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The index has shown a price loss of -65.47% this year. Over the last six months, there has been a weaker performance of 10.77%. The price of RVNC leaped by -47.49% during the last 30 days period. For the last 5-days stocks have slided -18.63%.
Revance Therapeutics Inc had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $9.74 on 01/02/24, while the lowest price during the same period was $2.30 on 06/26/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of RVNC Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Revance Therapeutics Inc’s current trading price is -68.86% away from its 52-week high, while its distance from the 52-week low is 31.96%. The stock’s price range over this timeframe has been between $2.30 and $9.74. The shares of the Healthcare sector company recorded a trading volume of approximately 14.71 million for the day, which was comparatively higher than the average daily volume of 2.87 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Revance Therapeutics Inc (RVNC) has experienced a quarterly decline of -53.81% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 308.68M and boasts a workforce of 597 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.09, with a change in price of -0.62. Similarly, Revance Therapeutics Inc recorded 3,919,836 in trading volume during the last 100 days, posting a change of -16.99%.
RVNC Stock Stochastic Average
Revance Therapeutics Inc’s raw stochastic average for the past 50 days is currently at 0.65%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 1.48%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 23.36% and 27.23%, respectively.
